Back to mobile site

UBS Reiterates Buy Rating on CME Group (CME)

July 3, 2025 9:12 AM EDT Send to a Friend
UBS analyst Alex Kramm reiterated a Buy rating and $305.00 price target on CME Group (NASDAQ: CME).The analyst commented, "Following ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login